Disclosure Insight

A report from Disclosure Insight reiterates its Medium Risk Negative Bias rating on Reynolds American (NYSE: RAI). The report states, “One-time items; turnover in the executive suite; turnover on the board; a substantial amount of pending litigation; concentrated revenue; and insider ownership...

A report from Disclosure Insight reiterates its Medium Risk rating on Netgear (NASDAQ: NTGR). The report states, “Concentrated revenue; patent infringement litigation; and the chairman and CEO positions being held by one person support our opinion of a Medium Risk - Negative Bias rating on NTGR....

A report from Disclosure Insight upgrades its rating from Medium Risk Negative Bias to Medium Risk Positive Bias on Koppers Holdings (NYSE: KOP). The report states, “We are changing our rating from Medium Risk - Negative Bias to Medium Risk - Positive Bias due stability in the executive suite...

A report from Disclosure Insight reiterates its Medium Risk Positive Bias rating on Comstock Resources (NYSE: CRK). The report states, “Concentrated revenue and a related party transaction support our opinion of a Medium Risk - Positive Bias rating for CRK. BP Energy Company and its subsidiaries...

A report from Disclosure Insight reiterates its Low Risk rating on Buckeye Technologies (NYSE: BKI). The report states, “The nature and timing of the risk factors we found support our opinion of a Low Risk rating for BKI.” BKI closed yesterday at $30.50.

A report from Disclosure Insight reiterates its Medium Risk Negative Bias rating on Brocade Communications (NASDAQ: BRCD). The report states, “Concentrated revenue; acquisition activity; ongoing patent litigation; and a new CFO in Jun-11 support our opinion of a Medium Risk - Negative Bias rating...

A report from Disclosure Insight reiterates its Medium Risk – Negative Bias rating on Xilinx (NASDAQ: XLNX). The report states, “Concentrated revenue; lowered guidance; and patent infringement litigation support our opinion of a Medium Risk - Negative Bias rating on XLNX. Resale of the company's...

A report from Disclosure Insight reiterates its Medium Risk – Negative Bias rating on Schlumberger Limited (NYSE: SLB). The report states, “Risk of undisclosed SEC activity; ongoing non-SEC investigative activity; acquisition activity; a recent CEO departure; and board turnover support our opinion...

A report from Disclosure Insight reiterates its Medium Risk – Positive Bias rating on P.F. Chang's China Bistro (NASDAQ: PFCB). The report states, “Recent guidance cuts; upcoming departures in the executive suite; and a co-CEO also serving as Chairman support our opinion of a Medium Risk -...

A report from Disclosure Insight reiterates its Medium Risk – Positive Bias rating on Meritage Homes (NYSE: MTH). The report states, “One-time items; related party transactions; and the chairman and CEO positions being held by one person support our opinion of a Medium Risk - Positive Bias rating...

A report from Disclosure Insight reiterates its Medium Risk – Negative Bias rating on MEMC Electronic Materials (NYSE: WFR). The report states, “Concentrated revenue; turnover in the executive suite; acquisition activity; lowered guidance; and patent infringement litigation support our opinion of...

A report from Disclosure Insight reiterates its Medium Risk – Negative Bias rating on Broadcom (NASDAQ: BRCM). The report states, “Insider ownership; multiple classes of stock; concentrated revenue; acquisition activity; board turnover; executive suite turnover; and restatements support our...

A report from Disclosure Insight reiterates its Medium Risk – Positive Bias rating on Ariba (NASDAQ: ARBA). The report states, “Acquisition activity; one-time items; and the chairman and CEO positions being held by one person support our opinion of a Medium Risk - Positive Bias rating for ARBA....

A report from Disclosure Insight reiterates its Medium Risk – Negative Bias rating on Allergan (NYSE: AGN). The report states, “ DOJ investigative activity; concentrated revenue; patent litigation; one-time items; acquisition activity; and the chairman and CEO positions being held by one person...

A report from Disclosure Insight reiterates its Medium Risk – Negative Bias rating on Watson Pharmaceuticals (NYSE: WPI). The report states, “Non-SEC investigative activity; litigation; concentrated revenue; and acquisition activity support our opinion of a Medium Risk - Negative Bias rating on...